the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Government has repaid RM42 billion of 1MDB debts, says PM Anwar

The government has paid RM42 billion to settle 1MDB debts since 2018, but RM9 billion in obligations remain, requiring RM13 billion in public funds.

KUALA LUMPUR: 1Malaysia Development Bhd’s (1MDB) debts have not been fully settled, with total financial obligations exceeding RM50 billion, said Prime Minister Datuk Seri Anwar Ibrahim.

Anwar, who is also the Finance Minister, said the government has already paid RM42 billion to settle 1MDB’s debts (principal and interest) and commitments from 2018 to date.

“The 1MDB debt inherited since 2018 amounts to RM34 billion in principal value and involves interest commitments of around RM17 billion,” he said at the Prime Minister’s question time in the Dewan Rakyat today.

ALSO READ: Malaysia’s national debt being repaid in stages to avoid disrupting development

Clarifying further, Anwar said only RM29 billion could be financed through funds derived from 1MDB asset recovery out of the RM42 billion paid by the government.

“This clearly shows that the asset recovery efforts are insufficient to cover 1MDB’s liability repayment commitments,” he added.

Anwar also said that the remaining 1MDB debt obligations require the use of government funds amounting to RM13 billion.

“This is a huge loss to the nation. The 1MDB debts have not been fully resolved, and 1MDB debt obligations of RM9 billion remain.

“This consists of the principal and interest of Islamic medium-term sukuk notes up to 2039, comprising RM5 billion in principal and RM4 billion in interest,” he said in response to a question from Syahredzan Johan (PH-Bangi). – Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings